Weather
Recent Quotes
My Watchlist
Indicators
Local Stocks
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Mirvie

New Study in JAMA Network Open Shows Current Approaches to Assessing Preeclampsia Risk Are Failing the Majority of Pregnant Moms
From Mirvie
Via Business Wire
Introducing Encompass™: A Breakthrough Solution from Mirvie to Advance Care for Pregnancy Complications
From Mirvie
Via Business Wire
Mirvie Announces Results from Largest Molecular Study in Pregnancy and Clinical Validation of Simple Blood Test to Predict Risk for Preeclampsia Months Before Symptoms
From Mirvie
Via Business Wire
Mirvie RNA Platform First to Uncover Unique Molecular Signal for Babies at Risk of Severe Fetal Growth Restriction
From Mirvie
Via Business Wire
Research Using Mirvie RNA Platform Selected for Plenary Session Presentation at the Society for Maternal and Fetal Medicine Annual Meeting
From Mirvie
Via Business Wire
New Campaign Brings to Forefront How Preeclampsia Prevention is Possible for Pregnant Women
From Mirvie
Via Business Wire
Mirvie Announces Completion of Enrollment of 10,000 Person Landmark Research Study for Pregnancy Health
From Mirvie
Via Business Wire
Mirvie Becomes First RNA-Based Pregnancy Health-Focused Company to Receive Clinical Laboratory Improvement Amendments (CLIA) Certification
From Mirvie
Via Business Wire
Mirvie Receives $4.6 Million Grant to Study Objective Prediction of Preeclampsia in Sub-Saharan Africa
From Mirvie
Via Business Wire
First Comprehensive Care Plan to Prevent Preeclampsia Published in the American Journal of Obstetrics and Gynecology
From Mirvie
Via Business Wire
First Ever “Future of Pregnancy Health” Report Reveals 9 out of 10 New or Expecting Moms Want More Information About Their Individual Risk of Pregnancy Complications to Optimize Prevention
From Mirvie
Via Business Wire
Mirvie Expands Leadership Team with Appointment of Alison Cowan, M.D. as Head of Medical Affairs
From Mirvie
Via Business Wire
Mirvie Raises $60 Million Funding Round to Shape the Future of Pregnancy Health
From Mirvie
Via Business Wire
Mirvie Receives FDA Breakthrough Device Designation for First Test Designed to Indicate Risk of Preeclampsia Months Before Symptoms Occur
From Mirvie
Via Business Wire
Study Published in The American Journal of Obstetrics and Gynecology Shows The Mirvie RNA Platform is First to Predict Preterm Birth by Revealing the Underlying Biology of Each Pregnancy
From Mirvie
Via Business Wire
Late-breaking Data Presented at SMFM 2022 Annual Meeting Shows The Mirvie RNA Platform is First to Reveal The Underlying Biology of Preterm Birth
From Mirvie
Via Business Wire
Study Published in Nature Shows Mirvie Can Predict Pregnancy Complications Months Before They Happen Using New, Proprietary RNA Platform
From Mirvie
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.